ST Elevations in the Era of COVID-19
Myocardial injury, represented by elevated cardiac enzymes, has been associated with increased morbidity and mortality in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Coronavirus disease 2019 (COVID-19) has created unique challenges in approaching patients with acute ST-s...
Saved in:
| Main Authors: | Charlie Joseph Sang, Brittain Heindl, Gregory Von Mering, Brigitta Brott, Robert S. Kopf, Indranee Rajapreyar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Cardiology |
| Online Access: | http://dx.doi.org/10.1155/2020/8845627 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ST Elevation Myocardial Infarction in Patients with COVID-19: Case Series
by: Sofia Lakhdar, et al.
Published: (2022-03-01) -
In-hospital outcomes of ST elevation myocardial infarction in post-COVID-19 patients
by: M. G. Chashchin, et al.
Published: (2023-03-01) -
Assessment Of COVID-19 Positive Patients With ST-Segment Elevation Myocardial Infarction During The COVID-19 Pandemic
by: Hakan Duman, et al.
Published: (2025-04-01) -
COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarction
by: Hisao Ogawa, et al.
Published: (2021-02-01) -
Review of Irish patients meeting ST elevation criteria during the COVID-19 pandemic
by: Richard Armstrong, et al.
Published: (2021-12-01)